Volume 99; Issue 7

Nihon Naika Gakkai Zasshi

Volume 99; Issue 7
2

1. Omalizumab (Xolair^|^reg;).

Year:
2010
File:
PDF, 507 KB
2010
3

Pirfenidone (PIRESPA^|^reg;)

Year:
2010
File:
PDF, 495 KB
2010
4

2. Anti-influenza Agents.

Year:
2010
File:
PDF, 364 KB
2010
5

VII. Antifungal Agents.

Year:
2010
File:
PDF, 460 KB
2010
6

2. Bevacizumab (AVASTIN^|^reg;)

Year:
2010
File:
PDF, 390 KB
2010
14

Diabetes Mellitus and Dementia.

Year:
2010
File:
PDF, 515 KB
2010
17

Very Acute Stage - the First Two Days.

Year:
2010
File:
PDF, 283 KB
2010
20

Notice for Members

Year:
2010
File:
PDF, 1.40 MB
2010
22

1. Bosentan (Tracleer^|^reg;)

Year:
2010
File:
PDF, 580 KB
2010
23

2. Phosphodiesterase-5 Inhibitors.

Year:
2010
File:
PDF, 389 KB
2010
24

IV. Prostacyclin Analogue.

Year:
2010
File:
PDF, 437 KB
2010
25

Rifabutin.

Year:
2010
File:
PDF, 299 KB
2010
28

Questions for Continuing Medical Education.

Year:
2010
File:
PDF, 243 KB
2010
32

Proteomics of Chronic Kidney Disease.

Year:
2010
File:
PDF, 812 KB
2010
33

Chest and Dorsal Pain.

Year:
2010
File:
PDF, 480 KB
2010
39

Information

Year:
2010
File:
PDF, 1.26 MB
2010
40

News

Year:
2010
File:
PDF, 169 KB
2010